Author

Linlin Zhang

University of LübeckORCID 0000-0002-4642-9617Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Linlin Zhang3 papers · Qilu Pharmaceutical Co., Ltd. (China)

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:protein structure· 1

Frequent Co-Authors

Alke MeentsiD· 1 shared F. LennartziD· 1 shared Helena TabermaniD· 1 shared J. WollenhauptiD· 1 shared Laila S. BenziD· 1 shared Manfred S. WeissiD· 1 shared Melanie OelkeriD· 1 shared Patrick Y. A. ReinkeiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Alke MeentsORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Enhancing the outcome of crystallographic screening for efficient drug discovery by choosing the right crystal form

Tatjana Barthel, J. Wollenhaupt, Laila S. Benz, Patrick Y. A. Reinke, Linlin Zhang, Melanie Oelker, F. Lennartz, Helena Taberman, U. Müeller, Alke Meents, Rolf Hilgenfeld, Manfred S. Weiss

This study shows that selecting the correct crystal form significantly improves hit rates in crystallographic fragment screening for drug discovery.

bioRxiv · Aug 20, 2025 · PreprintBiochemistry